TriSalus Life Sciences Inc.(TLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TLSI TriSalus Life Sciences Inc.

盘前交易 10-02 05:22:23 EDT

4.15

-0.16

-3.71%

最高4.27	最低4.02	成交量27.32万
今开4.27	昨收4.31	日振幅5.82%
总市值2.54亿	流通市值1.81亿	总股本6,131万
成交额113.24万	换手率0.63%	流通股本4,363万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TLSI","market":"US","secType":"STK","nameCN":"TriSalus Life Sciences Inc.","latestPrice":4.15,"timestamp":1790884800000,"preClose":4.31,"halted":0,"volume":273175,"delay":0,"changeRate":-0.03712296983758684,"floatShares":43631202,"shares":61306437,"eps":-1.33,"marketStatus":"盘前交易","change":-0.16,"latestTime":"10-02 05:22:23 EDT","open":4.27,"high":4.27,"low":4.0191,"amount":1132355.558145,"amplitude":0.058213,"askPrice":4.99,"askSize":100,"bidPrice":3.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.33,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790947800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":4.15,"postHourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.15,"latestTime":"19:30 EDT","volume":2940,"amount":12198.6,"timestamp":1790897405587,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6127343776037917},"requestUrl":"/m/hq/s/TLSI","defaultTab":"news","newsList":[{"id":"1164136974","title":"TriSalus Life Sciences：计划在未来数周内启动Trinav Advance设备的小规模市场发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1164136974","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164136974?lang=zh_cn&edition=full","pubTime":"2026-09-23 04:22","pubTimestamp":1790108549,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc.宣布，其预计将在未来几周内着手推进Trinav Advance设备的有限市场释放计划。这一举措标志着该公司在医疗技术领域迈出了重要一步，旨在逐步将其创新产品引入更广泛的临床应用场景。通过分阶段的市场投放策略，TriSalus旨在确保设备在实际使用中能够充分验证其性能与安全性，同时收集来自早期用户的宝贵反馈，为后续更大规模的推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163083250","title":"TriSalus生命科学旗下Trinav® Advance获FDA批准，强化肝脏栓塞压力介导药物递送（Pedd™）产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1163083250","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163083250?lang=zh_cn&edition=full","pubTime":"2026-09-23 04:16","pubTimestamp":1790108169,"startTime":"0","endTime":"0","summary":"TriSalus生命科学公司（TriSalus Life Sciences Inc.）近日宣布，其核心产品Trinav® Advance已获得美国食品药品监督管理局（FDA）的上市许可。这一里程碑式的进展，将显著增强该公司在肝脏栓塞治疗领域所构建的全面压力介导药物递送（Pedd™）产品组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105694795","title":"HC Wainwright首次覆盖TriSalus生命科学，给予买入评级与11美元目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1105694795","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105694795?lang=zh_cn&edition=full","pubTime":"2026-09-09 18:03","pubTimestamp":1788948191,"startTime":"0","endTime":"0","summary":"TriSalus生命科学公司近日获得H.C. Wainwright的首次覆盖，分析师给予其“买入”评级，并设定目标价为每股11美元。H.C. Wainwright在最新发布的研报中正式启动对这家生物制药企业的跟踪研究。报告指出，TriSalus专注于开发创新疗法，以改善肝脏和胰腺肿瘤患者的治疗结局，其平台技术具备差异化的临床价值。基于对产品管线进展和未来商业化潜力的评估，H.C. Wainwright给出了买入的建议，并将目标价锚定在11美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180317307","title":"TriSalus Life Sciences公布2026年第一季度业绩，商业与临床进展为长期增长奠定基础","url":"https://stock-news.laohu8.com/highlight/detail?id=1180317307","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180317307?lang=zh_cn&edition=full","pubTime":"2026-05-13 04:04","pubTimestamp":1778616278,"startTime":"0","endTime":"0","summary":"TriSalus Life Sciences Inc. (TLSI) 发布了2026年第一季度的财务与运营业绩，报告期内公司在商业推广和临床开发方面均取得了显著进展，这些成果为其未来的长期增长铺平了道路。\n业绩报告显示，公司核心产品的商业化势头强劲，市场渗透率持续提升。与此同时，多项关键临床研究也按计划推进，取得了积极的阶段性数据，进一步验证了其创新疗法的潜力和价值。\n公司管理层表示，第一季度的表现符合预期，商业与临床的双重进展是执行长期战略的直接体现。他们相信，这些坚实的基础工作将有力驱动公司价值在未来几个季度的持续释放。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518279899","title":"Trisalus Life Sciences, Inc.盘中异动 股价大跌5.04%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518279899?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:29","pubTimestamp":1741616997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时29分，Trisalus Life Sciences, Inc.股票出现异动，股价大幅下挫5.04%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体跌幅为1.27%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222957abf3124c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222957abf3124c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514501931","title":"Trisalus Life Sciences, Inc.盘中异动 快速下跌6.68%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514501931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514501931?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:49","pubTimestamp":1740498547,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时49分，Trisalus Life Sciences, Inc.股票出现波动，股价急速跳水6.68%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体跌幅为0.79%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225234907abdc9136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225234907abdc9136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509725323","title":"Trisalus Life Sciences, Inc.盘中异动 股价大涨5.61%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509725323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509725323?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:02","pubTimestamp":1738785766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时02分，Trisalus Life Sciences, Inc.股票出现异动，股价急速拉升5.61%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为1.36%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040246a23abf76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040246a23abf76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508144541","title":"Trisalus Life Sciences, Inc.盘中异动 急速拉升5.87%报5.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508144541?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:05","pubTimestamp":1738595153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时05分，Trisalus Life Sciences, Inc.股票出现异动，股价快速拉升5.87%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体跌幅为0.64%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230553abc10f09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203230553abc10f09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507436621","title":"Trisalus Life Sciences, Inc.盘中异动 早盘急速拉升7.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507436621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507436621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:32","pubTimestamp":1738247539,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分，Trisalus Life Sciences, Inc.股票出现异动，股价急速上涨7.36%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.52%。其相关个股中，Nanovibronix, Inc.、Pavmed Inc.、Trisalus Life Sciences, Inc.涨幅较大，Nanovibronix, Inc.、Intelligent Bio Solutions Inc.、Aethlon Medical, Inc.较为活跃，换手率分别为642.80%、1.37%、0.95%，振幅较大的相关个股有Nanovibronix, Inc.、古特拉、Pavmed Inc.，振幅分别为12.26%、9.64%、8.32%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223219a234553e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223219a234553e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507754857","title":"Trisalus Life Sciences, Inc.盘中异动 股价大跌5.66%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507754857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507754857?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:36","pubTimestamp":1738074996,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时36分，Trisalus Life Sciences, Inc.股票出现波动，股价快速下跌5.66%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.10%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282236369612f4ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282236369612f4ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505602611","title":"Trisalus Life Sciences, Inc.盘中异动 大幅拉升6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505602611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505602611?lang=zh_cn&edition=full","pubTime":"2025-01-24 05:00","pubTimestamp":1737666042,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日05时00分，Trisalus Life Sciences, Inc.股票出现波动，股价急速拉升6.63%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为1.09%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124050042abb645c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124050042abb645c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505726028","title":"Trisalus Life Sciences, Inc.盘中异动 早盘股价大涨5.97%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505726028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505726028?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:31","pubTimestamp":1737556264,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时31分，Trisalus Life Sciences, Inc.股票出现异动，股价大幅上涨5.97%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体跌幅为0.73%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223104a22bb120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223104a22bb120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503591606","title":"Trisalus Life Sciences, Inc.盘中异动 早盘股价大跌5.21%报4.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503591606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503591606?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:26","pubTimestamp":1737041201,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时26分，Trisalus Life Sciences, Inc.股票出现异动，股价急速下跌5.21%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为1.00%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501162326429868985a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501162326429868985a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503537167","title":"Trisalus Life Sciences, Inc.盘中异动 下午盘股价大跌5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503537167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503537167?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:51","pubTimestamp":1736797871,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日03时51分，Trisalus Life Sciences, Inc.股票出现波动，股价急速下挫5.86%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体跌幅为0.41%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114035111a2208a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114035111a2208a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502104893","title":"Trisalus Life Sciences, Inc.盘中异动 大幅上涨6.44%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502104893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502104893?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:33","pubTimestamp":1736519613,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时33分，Trisalus Life Sciences, Inc.股票出现异动，股价急速上涨6.44%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.11%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223333aba6034b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110223333aba6034b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502080715","title":"Trisalus Life Sciences, Inc.盘中异动 急速下跌5.63%报4.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502080715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502080715?lang=zh_cn&edition=full","pubTime":"2025-01-09 03:57","pubTimestamp":1736366264,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日03时57分，Trisalus Life Sciences, Inc.股票出现波动，股价快速下挫5.63%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为1.89%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109035744a21a9831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109035744a21a9831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494786210","title":"Trisalus Life Sciences, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494786210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494786210?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:05","pubTimestamp":1735229141,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日00时05分，Trisalus Life Sciences, Inc.股票出现异动，股价快速拉升5.26%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.11%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。TriNav 是采用 SmartValve 技术的最新治疗输送设备，适用于专有的 PEDD 方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700054195edf523&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700054195edf523&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493803490","title":"Trisalus Life Sciences, Inc.盘中异动 快速上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493803490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493803490?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:37","pubTimestamp":1735051022,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时37分，Trisalus Life Sciences, Inc.股票出现异动，股价快速拉升5.33%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.14%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223702a207c1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223702a207c1c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","TIVC","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493842505","title":"Trisalus Life Sciences, Inc.盘中异动 早盘急速上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493842505?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:31","pubTimestamp":1734705065,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时31分，Trisalus Life Sciences, Inc.股票出现异动，股价大幅拉升5.42%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.08%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122022310595ea9c0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122022310595ea9c0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492866174","title":"Trisalus Life Sciences, Inc.盘中异动 早盘股价大涨5.05%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492866174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492866174?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:35","pubTimestamp":1734618915,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时35分，Trisalus Life Sciences, Inc.股票出现波动，股价快速拉升5.05%。Trisalus Life Sciences, Inc.股票所在的医疗器械行业中，整体涨幅为0.55%。Trisalus Life Sciences, Inc.公司简介：TriSalus Life Sciences Inc从事创新药物输送技术和免疫肿瘤疗法的研究、开发和销售，以改善难治性肝癌和胰腺癌的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223528a1fb59e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223528a1fb59e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trisaluslifesci.com","stockEarnings":[{"period":"1week","weight":-0.0998},{"period":"1month","weight":-0.1973},{"period":"3month","weight":-0.1151},{"period":"6month","weight":-0.0212},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.4054}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0258},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.1429},{"period":"ytd","weight":0.1204}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TriSalus Life Sciences, Inc.于2020年9月11日在特拉华州注册成立。该公司是一家专注于肿瘤学的医疗技术企业，将其压力增强型药物递送技术与标准疗法及一种研究性免疫治疗药物相结合，旨在改善实体瘤患者的预后。其获得FDA批准的TriNav输液系统通过调节血管内的压力和流量，旨在增强血管内治疗药物的递送。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.038845},{"month":2,"riseRate":1,"avgChangeRate":0.042747},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.049602},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003546},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.075755},{"month":6,"riseRate":0.666667,"avgChangeRate":0.034089},{"month":7,"riseRate":0.5,"avgChangeRate":-0.043085},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.011579},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.093989},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051282},{"month":11,"riseRate":0.8,"avgChangeRate":0.107245},{"month":12,"riseRate":0.6,"avgChangeRate":0.243037}],"exchange":"NASDAQ","name":"TriSalus Life Sciences Inc.","nameEN":"TriSalus Life Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TriSalus Life Sciences Inc.(TLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TriSalus Life Sciences Inc.(TLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TriSalus Life Sciences Inc.,TLSI,TriSalus Life Sciences Inc.股票,TriSalus Life Sciences Inc.股票老虎,TriSalus Life Sciences Inc.股票老虎国际,TriSalus Life Sciences Inc.行情,TriSalus Life Sciences Inc.股票行情,TriSalus Life Sciences Inc.股价,TriSalus Life Sciences Inc.股市,TriSalus Life Sciences Inc.股票价格,TriSalus Life Sciences Inc.股票交易,TriSalus Life Sciences Inc.股票购买,TriSalus Life Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TriSalus Life Sciences Inc.(TLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TriSalus Life Sciences Inc.(TLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}